News
All →Publications
All →Report of the 49th meeting of the WHO Global Advisory Committee on Vaccine Safety, 27-28 November 2025
The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 as an independent expert advisory body to WHO on policies and issues related...
WHO Drug Information - Volume 39, No. 4
The Fourth issue of volume 39 for 2025 includes:Pharmaceutical News- Thin-Layer Chromatography: A Valuable Tool in the Fight Against Substandard/Falsified...
Advancing institutional compliance and continuous improvement in vaccine manufacturing: Virtual training...
The 2024 Virtual cGMP Training Marathon represented a crucial step towards strengthening local vaccine manufacturing capabilities in LMICs. This annual...
Driving quality across the product lifecycle for medicines, vaccines, biotherapeutic products, and in...
Ensuring quality of the health product ensures its safety and efficacy. Manufacturers in low- and middle-income countries (LMICs) face challenges to...
Related documents
Greener Pharmaceuticals' Regulatory Highway
An effective regulatory system plays a critical role in ensuring the quality of health products, spanning from their development in the laboratory to their...
Newsletters
All →WHO pharmaceuticals newsletter - No. 3, 2025
The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities...
WHO pharmaceuticals newsletter - No. 2, 2025
The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities...